Hydrogen Therapy Shows Promise for Treating Liver Disease

Authors
Journal
European Journal of Medical Reseach
Year
DOI
10.1186/s40001-025-03347-z
Study Type
clinical
Peer Reviewed
Yes
Country
China
Health Condition
Chronic Liver Disease
Body System
Hepatic

TL;DR

Scientists found that hydrogen gas might help treat liver disease by reducing harmful chemicals in your body and calming down inflammation, though they need to do more research to make sure it actually works in people.

Key Finding

Molecular hydrogen shows promise as a potential treatment for chronic liver diseases through its ability to reduce oxidative stress and inflammation, though most evidence comes from animal studies and early clinical trials rather than large-scale human research.

Summary

This review article examines how molecular hydrogen (a gas) might help treat liver diseases by looking at research from animal studies and clinical trials. The authors explain that hydrogen appears to work by reducing harmful molecules called free radicals and calming inflammation in the liver, which are two major problems in liver disease. They discuss how hydrogen might also help balance blood sugar and fat metabolism and improve the bacteria in the gut.

Practical Takeaway

While this review suggests hydrogen may have therapeutic potential for liver health based on preliminary research, it is a summary of existing studies rather than new evidence. The authors emphasize that more rigorous clinical trials in humans are needed before hydrogen therapy can be recommended as a standard treatment. Anyone with liver disease should consult their doctor before considering hydrogen as a therapeutic option.

Abstract

Oxidative stress and inflammation play a key role in the occurrence and progression of liver diseases, inducing hepatocyte apoptosis, fibrosis, and even cancer. However, there is a lack of effective therapeutic interventions to slow liver inflammation and the progression of metabolic liver diseases. The unique biological properties of molecular hydrogen's selective scavenging of pathological free radicals have shown therapeutic potential in animal studies and clinical trials of chronic liver diseases. This review describes innovative technologies and applications of molecular hydrogen in the treatment of liver injury and liver metabolic diseases, focusing on its mechanisms of action in regulating redox and inflammatory cascade signal transduction and specifically discussing its potential for glucolipid metabolic homeostasis and intestinal microbiota remodeling, as well as cell protection. Future studies are needed to further identify the unknown mechanisms by which molecular hydrogen improves the beneficial role of the liver microenvironment and advance the clinical application of hydrogen therapy.